MRSA – what is it, and how do we deal with the problem?

By Barrett John F  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 253-265

Informa Healthcare

Access to resources Recommend Favorite

Penetration of Antibacterials into Bone: What Do We Really Need to Know for Optimal Prophylaxis and Treatment of Bone and Joint Infections?

By Pea Federico  

Clinical Pharmacokinetics, Vol. 48, Iss. 2, 2009-01 ,pp. : 125-127

Adis International

Access to resources Recommend Favorite

We All Make Mistakes‐But What Can We Do About It?

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 4, 2002-12 ,pp. : 261-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

X-ray structural information of GPCRs in drug design: what are the limitations and where do we go?

By Topiol Sid  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 6, 2013-10 ,pp. : 607-620

Informa Healthcare

Access to resources Recommend Favorite

Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know

By Jones Drew R   Miller Grover P  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 857-874

Informa Healthcare

Access to resources Recommend Favorite